Markets

Valion Bio Regains NASDAQ Compliance

Sep 22, 2026 · 08:02 AM ET· updated 1h ago

Nasdaq confirms compliance with continued listing standard and closes the matterSAN ANTONIO, TX / ACCESS Newswire / September 22, 2026 / Valion Bio, Inc. (NASDAQ:VBIO) ("Valion" or the "Company) announced

Why It Matters

Valion Bio fixed its listing problem and can stay on NASDAQ. When a company fixes a compliance issue, it shows they got serious about their business.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

VBIO2.47

+0.09 (+3.95%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.